| Analysis of liver cancer cell lines identifies agents with likely efficacy against hepatocellular carcinoma and markers of response S Caruso, AL Calatayud, J Pilet, T La Bella, S Rekik, S Imbeaud, ... Gastroenterology 157 (3), 760-776, 2019 | 162 | 2019 |
| In hepatocellular carcinoma miR-221 modulates sorafenib resistance through inhibition of caspase-3–mediated apoptosis F Fornari, D Pollutri, C Patrizi, T La Bella, S Marinelli, A Casadei Gardini, ... Clinical cancer research 23 (14), 3953-3965, 2017 | 162 | 2017 |
| Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress Q Bayard, L Meunier, C Peneau, V Renault, J Shinde, JC Nault, I Mami, ... Nature Communications 9 (1), 5235, 2018 | 152 | 2018 |
| Hepatitis B virus integrations promote local and distant oncogenic driver alterations in hepatocellular carcinoma C Péneau, S Imbeaud, T La Bella, TZ Hirsch, S Caruso, J Calderaro, ... Gut 71 (3), 616-626, 2022 | 138 | 2022 |
| Adeno-associated virus in the liver: natural history and consequences in tumour development T La Bella, S Imbeaud, C Peneau, I Mami, S Datta, Q Bayard, S Caruso, ... Gut 69 (4), 737-747, 2020 | 108 | 2020 |
| Proliferation Markers Are Associated with MET Expression in Hepatocellular Carcinoma and Predict Tivantinib Sensitivity In Vitro S Rebouissou, T La Bella, S Rekik, S Imbeaud, AL Calatayud, ... Clinical Cancer Research 23 (15), 4364-4375, 2017 | 67 | 2017 |
| Wild-type AAV insertions in hepatocellular carcinoma do not inform debate over genotoxicity risk of vectorized AAV JC Nault, I Mami, T La Bella, S Datta, S Imbeaud, A Franconi, M Mallet, ... Molecular Therapy 24 (4), 660-661, 2016 | 50 | 2016 |
| Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress. Nat Commun. 2018; 9: 5235 Q Bayard, L Meunier, C Peneau, V Renault, J Shinde, JC Nault, I Mami, ... | 10 | |
| A functional mini-GDE transgene corrects impairment in models of glycogen storage disease type III A Gardin, J Rouillon, V Montalvo-Romeral, L Rossiaud, P Vidal, R Launay, ... The Journal of clinical investigation 134 (2), 2024 | 3 | 2024 |
| Liver fibrosis negatively impacts in vivo gene transfer to hepatocytes A Cantore, C Simoni, J Nozi, F Starinieri, T La Bella, E Manta, C Negri, ... | | 2024 |
| From AAV virus to AAV vector: characterization of a collection of AAV capsid variants isolated from human liver T La Bella, B Bertin, S Pezet, S Astord, J Nozi, A Mihaljevic, N Tedesco, ... HUMAN GENE THERAPY 33 (23-24), A29-A30, 2022 | | 2022 |
| Development of new AAV hybrid capsids with enhanced liver gene transfer properties J Nozi, B Bertin, A Mihaljevic, L Bergantz, T La Bella, G Ronzitti HUMAN GENE THERAPY 33 (23-24), A177-A178, 2022 | | 2022 |
| New adeno-associated virus (aav) variants and uses thereof for gene therapy J Zucman-Rossi, JC Nault, T La Bella, G Ronzitti, S Imbeaud, P Vidal | | 2020 |
| Adeno-associated virus in human liver: natural history and consequences in tumor development T La Bella, S Imbeaud, C Peneau, I Mami, S Datta, Q Bayard, S Caruso, ... HUMAN GENE THERAPY 30 (11), A3-A3, 2019 | | 2019 |
| DEGREE OF CELL DIFFERENTIATION AND ALTERATIONS IN RAS/MAPK PATHWAY PREDICT SENSITIVITY TO THE MEK INHIBITORS IN LIVER CANCER CELL LINES. S Caruso, AL Calatayud, J Pilet, T La Bella, S Rekik, S Imbeaud, ... HEPATOLOGY 70, 1141A-1142A, 2019 | | 2019 |
| Adeno-associated virus in the liver: natural history of the infection and consequences in tumor development T La Bella Sorbonne Paris Cité, 2018 | | 2018 |
